Tumour Reactions to Hypoxia

被引:39
|
作者
Voss, M. J. [1 ]
Niggemann, B. [1 ]
Zaenker, K. S. [1 ]
Entschladen, F. [1 ]
机构
[1] Univ Witten Herdecke, Inst Immunol, D-58448 Witten, Germany
关键词
Hypoxia; angiogenesis; lymphangiogenesis; neoneurogenesis; metabolic shift; cell migration; metastasis formation; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; INDUCIBLE FACTOR-I; PERINEURAL INVASION; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; NEUROTROPHIC FACTORS; INDUCED MIGRATION; CANCER CELLS; FACTOR VEGF;
D O I
10.2174/156652410791317020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fast growing solid tumours generally lack an inner organisation, which causes the problem of a sufficient nutrient of each part of the tumour that then happens only by diffusion. The low oxygen supply leads to the activation of hypoxia-inducible factors, which regulate a plethora of genes. The reaction of tumour cells to hypoxia can be divided into two parts: On the one hand, there are signal substances, predominantly growth factors and cytokines, which provoke the vascularisation (angiogenesis), lymph vessel development (lymphangiogenesis), and the innervation (neoneurogenesis) of tumours and thus connect the tumour to structures of the environment. On the other hand, genes for intracellular proteins and receptors are regulated, which lead to changes of the tumour cell functions. Best characterised is the metabolic shift, a high anaerobic glycolytic activity and simultaneously a reduction of respiration. Furthermore, proliferation, dedifferentiation, resistance to apoptosis, and the metastatic potential are affected. With regard to the latter, we herein show that the migratory activity and velocity of PC-3 human prostate carcinoma cells significantly increase under oxygen-deprivation, which might be an explanation for the increasing number of experimental and clinical hints, that an anti-angiogenic therapy can promote the metastasis formation.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [31] Hypoxia-mediated tumour targeting
    K Binley
    Z Askham
    L Martin
    H Spearman
    D Day
    S Kingsman
    S Naylor
    Gene Therapy, 2003, 10 : 540 - 549
  • [32] Exploiting tumour hypoxia in cancer treatment
    Brown, JM
    William, WR
    NATURE REVIEWS CANCER, 2004, 4 (06) : 437 - 447
  • [33] A NOVEL NITROFURAN FOR THE IMAGING OF TUMOUR HYPOXIA
    Ackermann, U.
    Chong, L. W.
    Yeoh, S. D.
    Rigopoulos, A.
    Tochon-Danguy, H.
    White, J.
    O'Keefe, G.
    Scott, A. M.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 9 - 9
  • [34] Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer
    Giatromanolaki, A
    Harris, AL
    ANTICANCER RESEARCH, 2001, 21 (6B) : 4317 - 4324
  • [35] Hypoxia and oxidative stress in breast cancer Tumour hypoxia – therapeutic considerations
    Kaye J Williams
    Rachel L Cowen
    Ian J Stratford
    Breast Cancer Research, 3
  • [36] The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
    Christine Blancher
    Adrian L. Harris
    Cancer and Metastasis Reviews, 1998, 17 : 187 - 194
  • [37] Hypoxia and oxidative stress in breast cancer - Tumour hypoxia - therapeutic considerations
    Williams, KJ
    Cowen, RL
    Stratford, IJ
    BREAST CANCER RESEARCH, 2001, 3 (05) : 328 - 331
  • [38] The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
    Blancher, C
    Harris, AL
    CANCER AND METASTASIS REVIEWS, 1998, 17 (02) : 187 - 194
  • [39] Eliminating tumour hypoxia to improve the impact of immunotherapy
    Marcus, D.
    Van der Wiel, A.
    Biemans, R.
    Lieuwes, N.
    Heyerick, A.
    Smaill, J.
    Patterson, A.
    Theys, J.
    Yaromina, A.
    Lambin, P.
    Dubois, L.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S102 - S102
  • [40] Role of macrophages in tumour angiogenesis: Regulation by hypoxia
    Lewis, J
    Landers, RJ
    Leek, RD
    Corke, K
    Harris, AL
    Lewis, CE
    JOURNAL OF PATHOLOGY, 1997, 182 : A1 - A1